Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Resverlogix Corp T.RVX

Alternate Symbol(s):  RVXCF

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.


TSX:RVX - Post by User

Post by general360on Jul 29, 2021 5:13pm
158 Views
Post# 33629565

buh bye july

buh bye julyforget about there goes the week, there goes another WHOLE month!

oh, but we're ready to go General!  full steam ahead!

i wonder if we're going to slip a bit into April? 

Yesterday, on CNBC, the angry bald man WHO IS ALWAYS SHOUTING, interviewed Albert Bourla, the CEO of Pfizer.  Ole Al said that Pfizer is investing ONE BILLION dollars on their COVID pill.  

ONE BILLION dollars.  that's correct, with a B.  They're doing this without any solid proof other than whatever data they have in hand already.  They're stepping up the manufacturing, partners, etc.  They're commiting this even tho they havent finished the P2/3 trials.

they're having no trouble with anything are they? no delays in starting, no issues w/ funding, and theyre getting a blank check to go full steam ahead. 

thats what full steam ahead means.
Our version of full steam ahead is to stick yer heed in the sand for MONTHS on end, only popping up every now and again to say stoooopid things like "WE'RE READY TO GO"

or these nuggets:

"by the end of the year"
"oh, but we do"
"April"
"walking out 48 hrs later"

trying to stay offline as much as possible, but NO MOVEMENT, backstopped by the stupid statements the CEO makes.... well,.........

thanks management, job well dun....


<< Previous
Bullboard Posts
Next >>